About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSouthwestern U.S.
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
20
As Collaborator
1
Total Enrollment
1,839
By Phase
PHASE3: 1PHASE1: 16PHASE2: 1PHASE1/PHASE2: 2
By Status
COMPLETED: 14WITHDRAWN: 5RECRUITING: 2
Clinical Trials Pipeline21 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05101187Lead Sponsor
Olorofim Aspergillus Infection Study
PHASE3Recruiting
225 participants
Started: Mar 31, 2022 · Completed: Nov 1, 2026
NCT05200286Lead Sponsor
A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment
PHASE1Completed
16 participants
Started: Feb 10, 2022 · Completed: Dec 13, 2022
NCT04752540Lead Sponsor
A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment
PHASE1Completed
32 participants
Started: Jul 2, 2021 · Completed: Oct 24, 2021
NCT04207957Lead Sponsor
A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim
PHASE1Completed
24 participants
Started: Dec 5, 2019 · Completed: Sep 15, 2020
NCT04171739Lead Sponsor
Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim
PHASE1Completed
24 participants
Started: Nov 18, 2019 · Completed: Feb 11, 2020
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...